Ameritas Advisory Services LLC lowered its position in shares of Stryker Co. (NYSE:SYK – Free Report) by 33.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities & ...
NEW YORK, NY / ACCESS Newswire / January 23, 2025 / Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered ...
According to a new market research report titled, 'Surgical Drills Market Size, Share, Forecast, & Trends Analysis by Product (Instruments [Pneumatic ...
The stock's fall snapped a five-day winning streak.
Florida-based NovApproach Spine LLC has named Kris Renton chief commercialization officer.
The global Bunion Surgery Market, valued at US$437.8 million in 2023, is forecasted to grow at a robust CAGR of 5.7%, reaching US$458.4 million in 2024 and an impressive US$606.1 million by 2029. The ...
Cross-Industry Advancements in Biotechnology and Pharmaceuticals Leading to Development of Advanced Wound Irrigation SolutionsRockville, MD, Jan. 22, 2025 (GLOBE NEWSWIRE) -- According to a recently ...
Stryker Corp (SYK) stock saw a modest uptick, ending the day at $383.42 which represents a slight increase of $1.63 or 0.43% from the prior close of $381.79. The stock opened at $385 and touched a low ...
The foundation aims to change systems that create intergenerational poverty, especially among populations of color.
UBS initiated coverage on Penumbra (NYSE:PEN), a medical technology company, with a Buy rating and a price target of $305.00.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback